Louise Locock1, Lorraine Smith. 1. Health Experiences Research Group, Department of Primary Health Care, University of Oxford, Headington, Oxford, UK. louise.locock@dphpc.ox.ac.uk
Abstract
BACKGROUND: Participation in clinical trials is critical for the success of evidence-based healthcare. Much previous research suggests that people take part in clinical trials mostly for altruistic reasons, and that deriving personal benefit is a secondary consideration. PURPOSE: To investigate patients' reasons for deciding whether to take part in clinical trials and the extent to which personal benefit may be a motivating factor. METHODS: A qualitative study utilizing in-depth semi-structured interviews. Participants were 42 men and women who had been asked to participate in clinical trials testing a range of interventions in different conditions, including some who did not participate or withdrew. Trials were based in either primary or secondary care. Interviews were conducted at home. RESULTS: Reasons for taking part were complex and a wide variety of personal considerations were evident. Gaining some personal benefit emerged as an important primary motivation in this group of respondents, whereas altruistic considerations appeared to be largely subsidiary. People who decided not to take part were also mainly concerned about the balance of personal risk and benefit. LIMITATIONS: Public dissemination of the results may have influenced participants' responses. CONCLUSIONS: Achieving target sample sizes for clinical trials may be enhanced by an understanding of what is likely to motivate patients to take part. In this study, respondents identified a range of attractive benefits, such as care in a specialist team with expert staff, active engagement in their health monitoring or care, more frequent or intensive monitoring, and information about the latest research into their condition.
BACKGROUND: Participation in clinical trials is critical for the success of evidence-based healthcare. Much previous research suggests that people take part in clinical trials mostly for altruistic reasons, and that deriving personal benefit is a secondary consideration. PURPOSE: To investigate patients' reasons for deciding whether to take part in clinical trials and the extent to which personal benefit may be a motivating factor. METHODS: A qualitative study utilizing in-depth semi-structured interviews. Participants were 42 men and women who had been asked to participate in clinical trials testing a range of interventions in different conditions, including some who did not participate or withdrew. Trials were based in either primary or secondary care. Interviews were conducted at home. RESULTS: Reasons for taking part were complex and a wide variety of personal considerations were evident. Gaining some personal benefit emerged as an important primary motivation in this group of respondents, whereas altruistic considerations appeared to be largely subsidiary. People who decided not to take part were also mainly concerned about the balance of personal risk and benefit. LIMITATIONS: Public dissemination of the results may have influenced participants' responses. CONCLUSIONS: Achieving target sample sizes for clinical trials may be enhanced by an understanding of what is likely to motivate patients to take part. In this study, respondents identified a range of attractive benefits, such as care in a specialist team with expert staff, active engagement in their health monitoring or care, more frequent or intensive monitoring, and information about the latest research into their condition.
Authors: D Lamunu; K N Chapman; P Nsubuga; G Muzanyi; Y Mulumba; M A Mugerwa; S Goldberg; L Bozeman; M Engle; J Saukkonen; S Mastranunzio; H Mayanja-Kizza; J L Johnson Journal: Int J Tuberc Lung Dis Date: 2012-04 Impact factor: 2.373
Authors: David L Mount; Cralen Davis; Betty Kennedy; Susan Raatz; Kathy Dotson; Tiffany L Gary-Webb; Sheikilya Thomas; Karen C Johnson; Mark A Espeland Journal: Clin Trials Date: 2011-11-07 Impact factor: 2.486
Authors: Mercedes de Jorge; Sonia Parra; Jenny de la Torre-Aboki; Gabriel Herrero-Beaumont Journal: Rheumatol Int Date: 2015-01-31 Impact factor: 2.631
Authors: Robert Pickard; Beatriz Goulao; Sonya Carnell; Jing Shen; Graeme MacLennan; John Norrie; Matt Breckons; Luke Vale; Paul Whybrow; Tim Rapley; Rebecca Forbes; Stephanie Currer; Mark Forrest; Jennifer Wilkinson; Elaine McColl; Daniela Andrich; Stewart Barclay; Jonathan Cook; Anthony Mundy; James N'Dow; Stephen Payne; Nick Watkin Journal: Health Technol Assess Date: 2020-11 Impact factor: 4.014
Authors: Alexia Iasonos; Mrinal Gounder; David R Spriggs; John F Gerecitano; David M Hyman; Sarah Zohar; John O'Quigley Journal: Clin Cancer Res Date: 2012-07-23 Impact factor: 12.531
Authors: K E A Burns; L Rizvi; O M Smith; Y Lee; J Lee; M Wang; M Brown; M Parker; A Premji; D Leung; M Hammond Mobilio; L Gotlib-Conn; R Nisenbaum; M Santos; Y Li; S Mehta Journal: Intensive Care Med Date: 2014-12-10 Impact factor: 17.440
Authors: Wendy C Bevier; Serena M Fuller; Ryan P Fuller; Richard R Rubin; Eyal Dassau; Francis J Doyle; Lois Jovanovič; Howard C Zisser Journal: Diabetes Technol Ther Date: 2014-05-08 Impact factor: 6.118
Authors: V Jenkins; V Farewell; D Farewell; J Darmanin; J Wagstaff; C Langridge; L Fallowfield Journal: Br J Cancer Date: 2013-03-19 Impact factor: 7.640